News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Simon A. Rothen

CEO of Sartec GmbH

Articles by Simon A. Rothen

Developing and Manufacturing Attenuated Live Bacterial Vaccines

ByAndre Collioud,Guido Dietrich,Simon A. Rothen

October 2nd 2008

There are a number of specific characteristics to be considered when developing and manufacturing live bacterial vaccines.

Latest Updated Articles

Developing and Manufacturing Attenuated Live Bacterial Vaccines
Published: October 2nd 2008 | Updated:

Trending on BioPharm International

What a High-Dose Nusinersen Option Means for Future SMA Care

Integrated Services for the Whole Drug Development Pathway

Weighing Digitalization Efficiency Against Upskilling and Quality Concerns

Implications of the First Liquid IV Infliximab Biosimilar

© 2025 MJH Life Sciences^®

All rights reserved.